Molecular Devices to Showcase the Latest Development with the SpectraMax® Paradigm® Platform with the Launch of a 'TUNE' Cartridge.

Molecular Devices is exhibiting on stand F3 at this year’s Drug Discovery 2011 meeting, held 7th – 8th September 2011 at Manchester Central, Manchester. They will be showcasing their latest product; the TUNE cartridge for the SpectraMax® Paradigm® Platform and will be able to offer advice and demonstrate the advantages of a future ready platform enabling users to perform an ever-evolving array of applications.

The breakthrough optical technology in TUNE, developed by Molecular Devices, combines free wavelength selection with up to 10X greater sensitivity than other monochromator-based systems. The only user upgradable microplate reader of its kind, SpectraMax® Paradigm® platform with TUNE lets you optimize excitation and emission wavelengths, assay at more physiologically relevant probe concentrations and find the best fit for your application, not your reader. Visit booth F3 to learn more.